Kairos Pharma (KAPA) Long-Term Debt Issuances (2024)
Kairos Pharma (KAPA) has disclosed Long-Term Debt Issuances for 1 consecutive years, with $40000.0 as the latest value for Q3 2024.
Kairos Pharma (KAPA) has disclosed Long-Term Debt Issuances for 1 consecutive years, with $40000.0 as the latest value for Q3 2024.